Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Antibodies seek out and mark the diseased cells for destruction ... Early diagnosis is still the best weapon against cancer ...

While bispecific antibodies tend to be well-tolerated for patients with multiple myeloma, there are still adverse effects clinicians should discuss with their patients. The use of bispecific ...